AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31931172 — intervention group
Group type: COMPARATOR
Intervention: Direct oral anticoagulants (DOACs)
Number of subjects: 84521
Study 31931172 — intervention group
Group type: COMPARATOR
Intervention: Dual therapy (OAC plus antiplatelet)
Number of subjects: 84521
Study 30053188 — intervention group
Group type: COMPARATOR
Intervention: PLA plus food transfers (10 kg fortified flour)
Number of subjects: 0
Study 30053188 — intervention group
Group type: COMPARATOR
Intervention: PLA only
Number of subjects: 0
Study 30053188 — intervention group
Group type: COMPARATOR
Intervention: All interventions
Number of subjects: 0
Study 30053188 — intervention group
Group type: COMPARATOR
Intervention: PLA plus cash transfers (750 Nepalese rupees)
Number of subjects: 0
Study 27514611 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga for 3 months
Number of subjects: 62
Study 27514611 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care for 3 months
Number of subjects: 62
Study 25231632 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive (COC) users
Number of subjects: 1372
Study 25231632 — intervention group
Group type: EXPERIMENTAL
Intervention: COC users with rs1799889 4G5G/5G5G genotype
Number of subjects: 1372
Study 25231632 — intervention group
Group type: EXPERIMENTAL
Intervention: Haplotype G-5G-T
Number of subjects: 1372
Study 25231632 — intervention group
Group type: EXPERIMENTAL
Intervention: Haplotype A-4G-G
Number of subjects: 1372
Study 22314555 — intervention group
Group type: EXPERIMENTAL
Intervention: Group H (AHG present)
Number of subjects: 34
Study 22314555 — intervention group
Group type: COMPARATOR
Intervention: Group L (AHG absent)
Number of subjects: 34
Study 20665344 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition counseling
Number of subjects: 0
Study 20665344 — intervention group
Group type: EXPERIMENTAL
Intervention: CES-D score
Number of subjects: 0
Study 18654768 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram 5 mg b.i.d after 1 week
Number of subjects: 16
Study 18654768 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose omeprazole 40 mg
Number of subjects: 16
Study 16191142 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (follow-up appointment made at discharge)
Number of subjects: 250
Study 16191142 — intervention group
Group type: COMPARATOR
Intervention: Standard group (given referral service phone number)
Number of subjects: 250
Study 12867221 — intervention group
Group type: EXPERIMENTAL
Intervention: IV gatifloxacin 400 mg QD with option for oral stepdown gatifloxacin
Number of subjects: 170
Study 12867221 — intervention group
Group type: COMPARATOR
Intervention: IV ceftriaxone 1 or 2 g QD (with or without erythromycin or clarithromycin) with option for oral stepdown clarithromycin
Number of subjects: 170
Study 11215862 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 122
Study 11215862 — intervention group
Group type: COMPARATOR
Intervention: Alfentanil
Number of subjects: 122
Study 8779018 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylaxis study group (110 patients)
Number of subjects: 329
Study 8779018 — intervention group
Group type: EXPERIMENTAL
Intervention: Coumadin group (part of prophylaxis study group)
Number of subjects: 329
Study 8779018 — intervention group
Group type: COMPARATOR
Intervention: Nonrandomized group (219 patients)
Number of subjects: 329
Study 8779018 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall clinical incidence
Number of subjects: 329
Study 1645995 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous fumarate
Number of subjects: 0
Study 1645995 — intervention group
Group type: COMPARATOR
Intervention: Ferrous sulphate
Number of subjects: 0
Study 1645995 — intervention group
Group type: COMPARATOR
Intervention: Ferric pyrophosphate
Number of subjects: 0
Study 1645995 — intervention group
Group type: COMPARATOR
Intervention: Ascorbic acid
Number of subjects: 0
Study 6677074 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical check-up
Number of subjects: 174
Study 6677074 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication
Number of subjects: 174
Study 6677074 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-therapy
Number of subjects: 174
Study 6677074 — intervention group
Group type: EXPERIMENTAL
Intervention: Employed alcoholics (older)
Number of subjects: 174
Study 6677074 — intervention group
Group type: COMPARATOR
Intervention: Employment status
Number of subjects: 174
Study 29887243 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy (CRT) with daily low-dose carboplatin
Number of subjects: 200
Study 29887243 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy (RT) alone
Number of subjects: 200
Study 28391237 — intervention group
Group type: EXPERIMENTAL
Intervention: Low vitamin D levels (< 50 nmol/L)
Number of subjects: 160
Study 28391237 — intervention group
Group type: COMPARATOR
Intervention: Normal vitamin D levels (≥ 50 nmol/L)
Number of subjects: 160
Study 26690208 — intervention group
Group type: EXPERIMENTAL
Intervention: SIPsmartER (SSB reduction group)
Number of subjects: 292
Study 26690208 — intervention group
Group type: COMPARATOR
Intervention: MoveMore (physical activity group)
Number of subjects: 292
Study 26690208 — intervention group
Group type: EXPERIMENTAL
Intervention: SIPsmartER
Number of subjects: 292
Study 23204255 — intervention group
Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition (early PN)
Number of subjects: 4640
Study 23204255 — intervention group
Group type: COMPARATOR
Intervention: Late parenteral nutrition (late PN)
Number of subjects: 4640
Study 23204255 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest dose of macronutrients
Number of subjects: 4640
Study 23204255 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher doses of macronutrients (administered parenterally or enterally)
Number of subjects: 4640
Study 23204255 — intervention group
Group type: EXPERIMENTAL
Intervention: Proteins/amino acids
Number of subjects: 4640
Study 23204255 — intervention group
Group type: EXPERIMENTAL
Intervention: Early combined parenteral/enteral nutrition
Number of subjects: 4640
Study 21169833 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy with stem cell rescue
Number of subjects: 0
Study 21169833 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy without stem cell rescue
Number of subjects: 0
Study 21169833 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 18047500 — intervention group
Group type: EXPERIMENTAL
Intervention: Rizatriptan 10 mg ODT
Number of subjects: 0
Study 18047500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16476679 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysterosalpingography (HSG) followed by laparoscopy and dye
Number of subjects: 344
Study 16476679 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopy and dye only
Number of subjects: 344
Study 14604250 — intervention group
Group type: EXPERIMENTAL
Intervention: Medtronic Affinity NT oxygenator
Number of subjects: 256
Study 14604250 — intervention group
Group type: COMPARATOR
Intervention: Cobe Optima XP oxygenator
Number of subjects: 256
Study 10707859 — intervention group
Group type: EXPERIMENTAL
Intervention: Sclerotherapy
Number of subjects: 200
Study 10707859 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligation
Number of subjects: 200
Study 10707859 — intervention group
Group type: COMPARATOR
Intervention: Sclerotherapy and Ligation
Number of subjects: 200
Study 9315420 — intervention group
Group type: EXPERIMENTAL
Intervention: Femcap with nonspermicidal lubricant (K'Y gel)
Number of subjects: 8
Study 9315420 — intervention group
Group type: EXPERIMENTAL
Intervention: Femcap with spermicide
Number of subjects: 8
Study 9315420 — intervention group
Group type: EXPERIMENTAL
Intervention: Ortho All‐Flex diaphragm with spermicide
Number of subjects: 8
Study 9315420 — intervention group
Group type: COMPARATOR
Intervention: Baseline cycles (no device)
Number of subjects: 8
Study 8227468 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol 400 mg
Number of subjects: 6
Study 8227468 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg
Number of subjects: 6
Study 8227468 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg
Number of subjects: 6
Study 8227468 — intervention group
Group type: COMPARATOR
Intervention: All drugs
Number of subjects: 6
Study 8227468 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 6
Study 3946803 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental (39.5 mg/kg)
Number of subjects: 182
Study 3946803 — intervention group
Group type: COMPARATOR
Intervention: Control (Fentanyl)
Number of subjects: 182
Study 29313731 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental guide for regulating video gaming
Number of subjects: 5864
Study 29313731 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no parental guide)
Number of subjects: 5864
Study 25792707 — intervention group
Group type: EXPERIMENTAL
Intervention: CXB+DFMO
Number of subjects: 112
Study 25792707 — intervention group
Group type: COMPARATOR
Intervention: CXB
Number of subjects: 112
Study 1534399 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-factor model of the McGill Pain Questionnaire Pain Rating Index (PRI)
Number of subjects: 1795
Study 1534399 — intervention group
Group type: EXPERIMENTAL
Intervention: McGill Pain Questionnaire Pain Rating Index (PRI)
Number of subjects: 1795
Study 1534399 — intervention group
Group type: EXPERIMENTAL
Intervention: Single subscale score from 10 PRI sensory subclasses
Number of subjects: 1795
Study 23787379 — intervention group
Group type: EXPERIMENTAL
Intervention: HPS simulation group
Number of subjects: 133
Study 23787379 — intervention group
Group type: COMPARATOR
Intervention: Paper and pencil case study group
Number of subjects: 133
Study 20545389 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cues
Number of subjects: 60
Study 20545389 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking imagery
Number of subjects: 60
Study 20545389 — intervention group
Group type: COMPARATOR
Intervention: Neutral cues
Number of subjects: 60
Study 20545389 — intervention group
Group type: COMPARATOR
Intervention: Neutral imagery
Number of subjects: 60
Study 18779282 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie deprivation (near calorie-free diet)
Number of subjects: 27
Study 18779282 — intervention group
Group type: COMPARATOR
Intervention: Fully fed diet
Number of subjects: 27
Study 15692526 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Trial Patient Preference Questionnaire (CTPPQ)
Number of subjects: 0
Study 15692526 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Practice Preference Questionnaire (CPPPQ)
Number of subjects: 0
Study 12942146 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Seizure Therapy (MST)
Number of subjects: 1
Study 10333102 — intervention group
Group type: EXPERIMENTAL
Intervention: Optic disc surface smoothness (ODSS) measurement in glaucomatous eyes
Number of subjects: 90
Study 10333102 — intervention group
Group type: COMPARATOR
Intervention: Optic disc surface smoothness (ODSS) measurement in normal eyes
Number of subjects: 90
Study 9375040 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive low-resolution telemedicine consultation with a paediatric radiologist
Number of subjects: 24
Study 9375040 — intervention group
Group type: COMPARATOR
Intervention: General radiologists' original diagnosis
Number of subjects: 24
Study 1680893 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin infusion (250 micrograms/h for 24 hours)
Number of subjects: 92
Study 1680893 — intervention group
Group type: COMPARATOR
Intervention: Sengstaken‐Blakemore tube (balloon tamponade for 48 hours)
Number of subjects: 92
Study 1680893 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of somatostatin and balloon tamponade
Number of subjects: 92
Study 7282105 — intervention group
Group type: EXPERIMENTAL
Intervention: Azapropazone
Number of subjects: 60
Study 7282105 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 60
Study 31146682 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilution parameter (d) estimated using mixed model with IGE and d.
Number of subjects: 3
Study 31146682 — intervention group
Group type: COMPARATOR
Intervention: Groups composed of two families vs. randomly composed groups.
Number of subjects: 3
Study 28498482 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal lifestyle intervention
Number of subjects: 374
Study 28498482 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 374
Study 28498482 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal gestational weight gain
Number of subjects: 374
Study 28498482 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal obesity
Number of subjects: 374
Study 26530646 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxinium (OxZr) femoral head with conventional polyethylene (CPE)
Number of subjects: 120
Study 26530646 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxinium (OxZr) femoral head with highly cross‐linked polyethylene (HXL)
Number of subjects: 120
Study 26530646 — intervention group
Group type: COMPARATOR
Intervention: Cobalt-chromium (CoCr) femoral head with conventional polyethylene (CPE)
Number of subjects: 120
Study 26530646 — intervention group
Group type: COMPARATOR
Intervention: Cobalt-chromium (CoCr) femoral head with highly cross‐linked polyethylene (HXL)
Number of subjects: 120
Study 23590124 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency exposure
Number of subjects: 0
Study 23590124 — intervention group
Group type: COMPARATOR
Intervention: Sham exposure
Number of subjects: 0
Study 18402307 — intervention group
Group type: EXPERIMENTAL
Intervention: Early (day 4) passive drainage
Number of subjects: 87
Study 18402307 — intervention group
Group type: COMPARATOR
Intervention: Late (day 10) passive drainage
Number of subjects: 87
Study 15564229 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaflets with assessment and up to seven intervention sessions by an occupational therapist
Number of subjects: 168
Study 15564229 — intervention group
Group type: COMPARATOR
Intervention: Leaflets describing local transport services for disabled people
Number of subjects: 168
Study 10896067 — intervention group
Group type: COMPARATOR
Intervention: Intravenous secretin (2 U/kg) plus placebo (Group 1)
Number of subjects: 40
Study 10896067 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous secretin (2 U/kg) plus cholecystokinin (0.02 microg/kg) (Group 2)
Number of subjects: 40
Study 10896067 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Group 1 and Group 2)
Number of subjects: 40
Study 9378668 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathic treatment (Nux vomica D200, Okoubaka D3, Tuberculinum D200, Barium jodatum D4, Barium jodatum D6)
Number of subjects: 82
Study 9378668 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 8317516 — intervention group
Group type: EXPERIMENTAL
Intervention: OC3 (35 micrograms ethinyl estradiol and 0.5 mg norethindrone)
Number of subjects: 192
Study 8317516 — intervention group
Group type: EXPERIMENTAL
Intervention: OC2 (35 micrograms ethinyl estradiol and 1.0 mg norethindrone)
Number of subjects: 192
Study 2941051 — intervention group
Group type: EXPERIMENTAL
Intervention: Daktacort (2% miconazole base and 1% hydrocortisone)
Number of subjects: 70
Study 2941051 — intervention group
Group type: EXPERIMENTAL
Intervention: Miconazole (2% miconazole base)
Number of subjects: 70
Study 2941051 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone (1% hydrocortisone)
Number of subjects: 70
Study 31859725 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-octyl-cyanoacrylate
Number of subjects: 79
Study 31859725 — intervention group
Group type: COMPARATOR
Intervention: Nylon suture
Number of subjects: 79
Study 29103340 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegberon plus ribavirin
Number of subjects: 770
Study 29103340 — intervention group
Group type: COMPARATOR
Intervention: Pegasys plus ribavirin
Number of subjects: 770
Study 29103340 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline ATA positive patients
Number of subjects: 770
Study 29103340 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline ATA negative patients
Number of subjects: 770
Study 29103340 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline NAb positive patients
Number of subjects: 770
Study 29103340 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline NAb negative patients
Number of subjects: 770
Study 29103340 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced ATA positive patients
Number of subjects: 770
Study 29103340 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained ATA negative patients
Number of subjects: 770
Study 29103340 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegberon
Number of subjects: 770
Study 29103340 — intervention group
Group type: COMPARATOR
Intervention: Pegasys
Number of subjects: 770
Study 26751473 — intervention group
Group type: EXPERIMENTAL
Intervention: NutriRice
Number of subjects: 2440
Study 26751473 — intervention group
Group type: EXPERIMENTAL
Intervention: URN
Number of subjects: 2440
Study 26751473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2440
Study 24528935 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of hyaluronate and diquafosol
Number of subjects: 105
Study 24528935 — intervention group
Group type: COMPARATOR
Intervention: Sodium hyaluronate
Number of subjects: 105
Study 24528935 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears
Number of subjects: 105
Study 24528935 — intervention group
Group type: COMPARATOR
Intervention: Diquafosol tetrasodium
Number of subjects: 105
Study 22238339 — intervention group
Group type: EXPERIMENTAL
Intervention: DepoFoam bupivacaine (133 or 266 mg)
Number of subjects: 94
Study 22238339 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine HCl (75 mg)
Number of subjects: 94
Study 22238339 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine HCl (200 mg)
Number of subjects: 94
Study 22238339 — intervention group
Group type: EXPERIMENTAL
Intervention: DepoFoam bupivacaine (532 mg)
Number of subjects: 94
Study 19279561 — intervention group
Group type: EXPERIMENTAL
Intervention: NIC gum treatment
Number of subjects: 0
Study 19279561 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study 19279561 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2A6 genotype group
Number of subjects: 0
Study 17192761 — intervention group
Group type: EXPERIMENTAL
Intervention: STS 6 mg/24 hr
Number of subjects: 12
Study 17192761 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 15923689 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc and copper supplementation (40 mg of zinc sulfate and 5 mg of copper sulfate in ORS)
Number of subjects: 200
Study 15923689 — intervention group
Group type: COMPARATOR
Intervention: Placebo (50 mg of standard ORS powder in ORS)
Number of subjects: 200
Study 15923689 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc and copper supplementation
Number of subjects: 200
Study 15923689 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 12414874 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (a nonspecific COX‐1 and COX‐2 inhibitor)
Number of subjects: 32
Study 12414874 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac (predominantly a COX‐2 inhibitor)
Number of subjects: 32
Study 12414874 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib (a specific COX‐2 inhibitor)
Number of subjects: 32
Study 12414874 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 9682122 — intervention group
Group type: COMPARATOR
Intervention: 10‐1 nylon anchor suture
Number of subjects: 126
Study 9682122 — intervention group
Group type: EXPERIMENTAL
Intervention: cyanoacrylate (Histoacryl)
Number of subjects: 126
Study 9682122 — intervention group
Group type: EXPERIMENTAL
Intervention: fibrinogen (Tissucol)
Number of subjects: 126
Study 7887333 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency-doubled Nd:YAG laser
Number of subjects: 13
Study 7887333 — intervention group
Group type: EXPERIMENTAL
Intervention: Krypton laser
Number of subjects: 13
Study 7887333 — intervention group
Group type: COMPARATOR
Intervention: Diode laser
Number of subjects: 13
Study 2403834 — intervention group
Group type: EXPERIMENTAL
Intervention: CMFPT
Number of subjects: 553
Study 2403834 — intervention group
Group type: COMPARATOR
Intervention: CMF
Number of subjects: 553
Study 2403834 — intervention group
Group type: EXPERIMENTAL
Intervention: CMFP
Number of subjects: 553
Study 755865 — intervention group
Group type: EXPERIMENTAL
Intervention: autogenic training
Number of subjects: 30
Study 755865 — intervention group
Group type: EXPERIMENTAL
Intervention: combination of autogenic training and skin temperature feedback
Number of subjects: 30
Study 31616975 — intervention group
Group type: EXPERIMENTAL
Intervention: Columellar strut graft
Number of subjects: 44
Study 31616975 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue-in-groove
Number of subjects: 44
Study 31616975 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 44
Study 31127818 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat delivered to the distal small intestine in delayed release microcapsules
Number of subjects: 8
Study 31127818 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate or protein delivered in gastric release formulations
Number of subjects: 8
Study 31127818 — intervention group
Group type: COMPARATOR
Intervention: Fat delivered in gastric release formulations
Number of subjects: 8
Study 31127818 — intervention group
Group type: EXPERIMENTAL
Intervention: Food intake after consumption of fat at distal small intestine
Number of subjects: 8
Study 29220633 — intervention group
Group type: EXPERIMENTAL
Intervention: suicide‐focused intervention
Number of subjects: 62
Study 29220633 — intervention group
Group type: COMPARATOR
Intervention: treatment‐as‐usual condition
Number of subjects: 62
Study 29220633 — intervention group
Group type: EXPERIMENTAL
Intervention: comprehensive and multimodal suicide‐focused intervention
Number of subjects: 62
Study 29220633 — intervention group
Group type: EXPERIMENTAL
Intervention: flexible and theoretically agnostic suicide‐focused intervention
Number of subjects: 62
Study 29220633 — intervention group
Group type: EXPERIMENTAL
Intervention: overall SMART approach
Number of subjects: 62
Study 26011337 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EEN)
Number of subjects: 400